Skip to main content
. 2018 Oct 22;43(1):155–166. doi: 10.3892/ijmm.2018.3945

Table III.

Characteristics of the patients with congenital hypopituitarism and controls in the validation set.

Characteristics Congenital hypopituitarism, n=40 Controls, n=40 P-value
Basic information
 Age, years 26.49±3.42 25.08±3.56 0.143
 Height, cm 166.7±8.71 171.5±6.34 0.093
 Weight, kg 63.28±14.92 65.31±7.06 0.068
 BMI, kg/m2 23.10±4.19 22.23±2.31 0.768
Thyroid function
 FT3, pmol/l 3.77 (2.57-5.07) 4.19 (2.32-5.43) 0.196
 FT4, pmol/l 11.28 (6.96-16.92) 12.45 (7.34-17.08) 0.090
 TSH, µIU/l 0.15 (0.00-4.42) 1.53 (0.56-3.25) <0.001
Corticotropic function
 Cortisol, µg/dl 3.01 (0.13-19.13) 13.69 (7.10-21.21) <0.001
 ACTH, pg/ml 20.54 (4.65-60.15) 43.00 (20.00-55.00) <0.001
Gonadotropic function
 LH, mIU/l 0.18 (0.01-3.98) 3.82 (1.27-8.26) <0.0001
 FSH, µIU/ml 0.72 (0.05-6.16) 5.04 (1.45-10.36) <0.0001
 PRL, ng/ml 15.79 (1.63-54.57) 8.32 (3.56-11.67) <0.0001
 E2, pg/ml 24.30 (20.00-68.90) 23.00 (20.00-45.40) 0.8898
 PROG, ng/ml 0.10 (0.10-0.49) 0.10 (0.10-0.89) 0.1731
 TESTO, ng/ml 2.59 (0.10-10.67) 4.31 (2.25-7.02) 0.0429

The data for basic information are presented as the mean ± standard deviation. All other data are presented as the median (range). ACTH, adrenocorticotropic hormone; BMI, body mass index; FT3, free thyroxine 3; FT4, free thyroxine 4; TSH, thyroid stimulating hormone; PRL, prolactin; PROG, progesterone; TESTO, testosterone; LH, luteinising hormone; FSH, follicle-stimulating hormone.